NDC 68516-5214-01 - ALBUTEIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68516-5214
- Requested NDC
- 68516-5214-01
- Package NDCs from labels
- 68516-5214-7, 68516-5214-9, 68516-5214-8, 68516-5214-0, 68516-5214-3, 68516-5214-1, 68516-5214-4, 68516-5214-2, 68516-5214-6, 68516-5214-5, 68516-5214-01
- Manufacturer
- GRIFOLS USA, LLC | Grifols Biologicals LLC
- Effective date
- 2026-10-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ALBUTEIN - GRIFOLS USA, LLC | Grifols Biologicals LLC | GRIFOLS USA, LLC | Grifols Biologicals LLC | 2026-10-14 | PLASMA DERIVATIVE |
| ALBUTEIN - GRIFOLS USA, LLC | Grifols Biologicals LLC | Grifols Therapeutics LLC | INSTITUTO GRIFOLS SA | GRIFOLS USA, LLC | Grifols Biologicals LLC | Grifols Therapeutics LLC | INSTITUTO GRIFOLS SA | 2025-05-28 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68516-5214-1 | ALBUTEIN | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 17 | |
| 68516-5214-2 | ALBUTEIN | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 17 | |
| 68516-5214-3 | ALBUTEIN | 250 mL in 1 VIAL | INJECTION, SOLUTION | 250 | 17 | |
| 68516-5214-4 | ALBUTEIN | 500 mL in 1 VIAL | INJECTION, SOLUTION | 500 | 17 | |
| 68516-5214-5 | ALBUTEIN | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 17 | |
| 68516-5214-6 | ALBUTEIN | 50 mL in 1 VIAL | INJECTION, SOLUTION | 50 | 17 | |
| 68516-5214-0 | ALBUTEIN | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 13 | |
| 68516-5214-7 | ALBUTEIN | 250 mL in 1 BAG | INJECTION, SOLUTION | 250 | 13 | |
| 68516-5214-8 | ALBUTEIN | 500 mL in 1 BAG | INJECTION, SOLUTION | 500 | 13 | |
| 68516-5214-9 | ALBUTEIN | 4 in 1 CARTON | INJECTION, SOLUTION | 4 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68516-5214 | ALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC] | 16 | Current NDC, Legacy NDC, 6 package rows | 20231108_9c45986e-4e62-4f7d-971c-bec74dc4d234.zip |
| 68516-5214 | ALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC] | 12 | Current NDC, Legacy NDC, 4 package rows | 20250406_a6ca2871-9a9d-4f03-a5ff-ddb28c6ff945.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68516-5214-0 | ML - Milliliter | 68516-5214 | c95a1501-c502-4b77-ad00-ad19e53d8b82 | 1 | 2021-12-08 |
| 68516-5214-1 | ML - Milliliter | 68516-5214 | 7a55218d-41af-4c23-8aa0-f1931642647a | 1 | 2012-07-24 |
| 68516-5214-2 | ML - Milliliter | 68516-5214 | 7cc5cefc-1bc3-44f3-a6cb-ac03a9e917fc | 1 | 2012-07-24 |
| 68516-5214-3 | ML - Milliliter | 68516-5214 | 4519dd7e-f0f9-4663-a534-db77235c4429 | 1 | 2014-10-03 |
| 68516-5214-4 | ML - Milliliter | 68516-5214 | 780e43ea-0794-4862-aefd-e766ade037c1 | 1 | 2014-10-03 |
| 68516-5214-5 | ML - Milliliter | 68516-5214 | 5c6eb1af-1152-48a4-b5bf-a616bfe2e01f | 1 | 2016-07-19 |
| 68516-5214-6 | ML - Milliliter | 68516-5214 | 51b3a042-515f-4d1a-a3dd-9118ecb6b7e6 | 1 | 2016-07-19 |
| 68516-5214-7 | ML - Milliliter | 68516-5214 | 24fc8f17-29aa-42aa-9ea9-c916c1ca9f59 | 1 | 2021-12-08 |
| 68516-5214-8 | ML - Milliliter | 68516-5214 | c46f6074-a864-4a39-a729-36a796efa75d | 1 | 2021-12-08 |
| 68516-5214-9 | ML - Milliliter | 68516-5214 | 5c158552-cc7f-41ce-b467-ea433c5f982e | 1 | 2021-12-08 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Albumin (Human) | ACTIVE INGREDIENT | ZIF514RVZR | ALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC] | 3 | |
| Albumin (Human) | ACTIVE MOIETY | ZIF514RVZR | ALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC] | 3 | |
| Sodium Acetyltryptophanate | INACTIVE INGREDIENT | 3EN9H0M2FX | ALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC] | 3 | |
| Sodium Caprylate | INACTIVE INGREDIENT | 9XTM81VK2B | ALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC] | 3 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | ALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC] | 3 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | ALBUTEIN (ALBUMIN (HUMAN)) INJECTION, SOLUTION [GRIFOLS USA, LLC] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cold Sore Formula | DULCAMARA, GLYCYRRHIZA GLABRA, RANUNCULUS BULBOSUS, RHUS TOX, NATRUM MURIATICUM, FAGOPYRUM ESCULENTUM, NATRUM HYPOCHLOROUS, ACONITUM NAPELLUS, CYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX I AND II NOSODE, SEPIA, EPSTEIN BARR VIRUS NOSODE, HERPES ZOSTER NOSODE, ADENOVIREN NOSODE | Nutritional Specialties, Inc. | ad6a08ec-5eba-405b-8a07-79ac86ab3e7a | 2026-03-31 | Warnings | 451W47IQ8X |
| ANX HP | ARSENICUM ALBUM, CALCAREA CARBONICA, IGNATIA AMARA, KALI CARBONICUM, LACHESIS MUTUS, NATRUM MURIATICUM | BioActive Nutritional, Inc. | 96035891-aea3-4138-bb26-801ad819f639 | 2026-03-30 | Warnings | 451W47IQ8X |
| Spleen Liquescence | QUERCUS ROBUR, CEANOTHUS AMERICANUS, SPLEEN (BOVINE), NATRUM MURIATICUM, HELIANTHUS ANNUUS | Nutritional Specialties, Inc. | d800456d-60f0-413d-b310-91b8b881f6b9 | 2026-03-30 | Warnings | 451W47IQ8X |
| Depressoforce | PICRICUM ACIDUM, ARSENICUM ALBUM, AURUM METALLICUM, IGNATIA AMARA, NATRUM MURIATICUM, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SEPIA | BioActive Nutritional, Inc. | e6b98979-a38c-4f13-af03-f5ffa962b4fa | 2026-03-27 | Warnings | 451W47IQ8X |
| Adrenapar | ARALIA QUINQUEFOLIA, AVENA SATIVA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS SUIS, ARSENICUM IODATUM, CALCAREA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ZINCUM METALLICUM | Energique, Inc. | 077a9171-283d-47b6-bddc-34c739f6d69d | 2026-03-27 | Warnings | 451W47IQ8X |
| Buffer pH | CHAMOMILLA, GRAPHITES, KALI CARBONICUM, KALI OXALICUM, KALI PHOSPHORICUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SULPHURICUM, NUX VOMICA, RHEUM (PALMATUM), ROBINIA PSEUDOACACIA | NaturalCare | 2161a2e2-613d-4dac-a5f6-796d40e849d9 | 2026-03-25 | Warnings | 451W47IQ8X |
| Worafy Gentle Eye Wash | SODIUM CHLORIDE | Shenzhen Shandian Jingling Technology Co., Ltd. | 4da864dc-e10c-1db9-e063-6394a90a0984 | 2026-03-22 | Warnings | 451W47IQ8X |
| SODIUM CHLORIDE HYPERTONICITY | SODIUM CHLORIDE | YYBA CORP | 439653b9-99b8-4799-8d67-4a2ada9c6783 | 2026-03-20 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | Hospira, Inc. | 2b9ea23a-f9e9-48a8-25b7-519e3bbd6828 | 2026-03-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Altachlore Sodium Chloride Hypertonicity Ophthalmic 5 Percent | SODIUM CHLORIDE | Altaire Pharmaceuticals Inc. | e13fd053-9420-490c-a43e-e14b0930cb4e | 2026-03-18 | Warnings | 451W47IQ8X |
| Universaltox | ALFALFA, AVENA SATIVA, FUCUS VESICULOSUS, HORDEUM VULGARE, NASTURTIUM AQUATICUM, RAPHANUS SATIVUS, TRITICUM AESTIVUM, IODIUM, UBIDECARENONUM, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, MANGANESE GLUCONATE, ORYZA SATIVA, THYROIDINUM (SUIS), CALCAREA CARBONICA, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), RHUS TOX, CORTISONE ACETICUM | BioActive Nutritional, Inc. | ad454e8a-4f78-4aac-90d9-a3f26a6fbe42 | 2026-03-17 | Warnings | 451W47IQ8X |
| TINTED SUNSCREEN FOUNDATION | TINTED SUNSCREEN FOUNDATION | Guanghzou AiXin Biotech Co Ltd | 396393c4-b50c-3877-e063-6294a90a0e9b | 2026-03-17 | Warnings | 059QF0KO0R |
| BM BIO27 | CALC PHOS, KALI PHOS, NAT MUR | BM Private Limited | 4d229815-05f4-27c5-e063-6394a90ac865 | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO1 | CALC PHOS, FERR PHOS, KALI PHOS, NAT MUR | BM Private Limited | 4d265d99-fdbb-5efb-e063-6394a90a89ac | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO16 | CALC PHOS, FERR PHOS, KALI PHOS, MAG PHOS, NAT MUR. | BM Private Limited | 4d26b4a9-ee27-6915-e063-6294a90a5d4d | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO12 | FERR PHOS, KALI PHOS, MAG PHOS, NAT MUR. | BM Private Limited | 4d2747ad-958e-63a1-e063-6294a90aea66 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b812c9-fb0a-5ee0-e063-6294a90a03e1 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b88e7c-eca0-5540-e063-6294a90a1b18 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b8c3f4-e528-c69d-e063-6294a90a5a34 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Laboratoire Unither | 31b7eb13-39c3-6f0e-e063-6394a90a4011 | 2026-03-16 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.